Capstone Investment Advisors
TXG icon

Capstone Investment Advisors’s 10x Genomics TXG Stock Holding History

Capstone Investment Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,776
Closed -$348K – 2063
2025
Q3 		$348K Buy
+29,776
New +$388K ﹤0.01% 1577
2024
Q3 		– Sell
-12,677
Closed -$247K – 2211
2024
Q2 		$247K Sell
12,677
-3,438
-21% -$90K ﹤0.01% 1678
2024
Q1 		$605K Buy
16,115
+10,589
+192% +$465K ﹤0.01% 1456
2023
Q4 		$309K Buy
+5,526
New +$240K ﹤0.01% 1579

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capstone Investment Advisors's TXG Position: Q4 2025 in Review

Capstone Investment Advisors sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 29,776 shares — an estimated $348K sold.

Capstone Investment Advisors first reported a position in TXG in Q4 2023 and held it in 4 quarters. The position peaked at $605K in Q1 2024. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Capstone Investment Advisors reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 29,776 10x Genomics shares in Q4 2025, an estimated $348K.
  • Capstone Investment Advisors first reported a position in 10x Genomics in Q4 2023 and held it in 4 quarters.
  • Capstone Investment Advisors's 10x Genomics position peaked at $605K in Q1 2024.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.